UK markets closed

N4 Pharma Plc (N4P.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
0.80000.0000 (0.00%)
At close: 02:02PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1.953
1.953
0
0
0
Operating expenses
Research development
619.392
619.392
577.525
1,179
900.41
Selling general and administrative
717.98
717.98
615.735
663.865
664.011
Total operating expenses
1,337
1,337
1,193
1,843
1,564
Operating income or loss
-1,335
-1,335
-1,193
-1,843
-1,564
Interest expense
-
-
-
-
1.963
Income before tax
-1,425
-1,425
-1,193
-1,843
-1,566
Income tax expense
-147.816
-147.816
-163.998
-298.267
-261.541
Income from continuing operations
-1,277
-1,277
-1,029
-1,544
-1,305
Net income
-1,269
-1,269
-1,029
-1,544
-1,305
Net income available to common shareholders
-1,269
-1,269
-1,029
-1,544
-1,305
Basic EPS
-0.00
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-0.00
-0.01
-0.01
-0.01
-0.01
Basic average shares
212,773
242,890
186,423
181,080
136,303
Diluted average shares
212,773
242,890
186,423
181,080
139,432